Literature DB >> 23883597

Chronic rhinosinusitis: epidemiology and cost.

Akaber M Halawi1, Stephanie Shintani Smith, Rakesh K Chandra.   

Abstract

Chronic rhinosinusitis (CRS) is one of the most common chronic diseases and is associated with a high socioeconomic burden from direct and indirect costs. Its estimated prevalence ranges widely, from 2 to 16%. It is more common in female subjects, aged 18-64 years, and in southern and midwestern regions of the United States. CRS is more prevalent in patients with comorbid diseases such as asthma, chronic obstructive pulmonary disease, and environmental allergies. Few studies examine patient ethnicity, socioeconomic status, geographic location, and cultural factors in CRS populations. This article provides an overview of the epidemiology, racial variations, and economic burden of CRS.

Entities:  

Mesh:

Year:  2013        PMID: 23883597     DOI: 10.2500/aap.2013.34.3675

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  34 in total

1.  CHEER National Study of Chronic Rhinosinusitis Practice Patterns: Disease Comorbidities and Factors Associated with Surgery.

Authors:  Nikita Chapurin; Melissa A Pynnonen; Rhonda Roberts; Kristine Schulz; Jennifer J Shin; David L Witsell; Kourosh Parham; Alan Langman; David Carpenter; Andrea Vambutas; Anh Nguyen-Huynh; Anne Wolfley; Walter T Lee
Journal:  Otolaryngol Head Neck Surg       Date:  2017-02-14       Impact factor: 3.497

2.  Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis.

Authors:  Zachary M Soler; Frederick Yoo; Rodney J Schlosser; Jennifer Mulligan; Vijay R Ramakrishnan; Daniel M Beswick; Jeremiah A Alt; Jose L Mattos; Spencer C Payne; Kristina A Storck; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2019-12-19       Impact factor: 3.858

3.  Lipidomic profiling of sinus mucosa from patients with chronic rhinosinusitis.

Authors:  Farbod Fazlollahi; Kessiri Kongmanas; Nongnuj Tanphaichitr; Jon Mallen-St Clair; Quinton Gopen; Kym F Faull; Jeffrey D Suh
Journal:  Clin Transl Sci       Date:  2015-01-15       Impact factor: 4.689

4.  Efficacy of steroid-eluting stents in management of chronic rhinosinusitis after endoscopic sinus surgery: updated meta-analysis.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Arash Abiri; Tyler Yasaka; Ronald Sahyouni; Benjamin Bitner; Bobby A Tajudeen; Edward C Kuan
Journal:  Int Forum Allergy Rhinol       Date:  2019-09-20       Impact factor: 3.858

5.  Association of Chronic Rhinosinusitis With Depression and Anxiety in a Nationwide Insurance Population.

Authors:  Jong-Yeup Kim; Inseok Ko; Myoung Suk Kim; Myeong Sang Yu; Bum-Joo Cho; Dong-Kyu Kim
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-04-01       Impact factor: 6.223

6.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

Review 7.  Economics of Chronic Rhinosinusitis.

Authors:  Luke Rudmik
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.806

Review 8.  Relationships among allergic rhinitis, asthma, and chronic rhinosinusitis.

Authors:  Mariel G Rosati; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2016 Jan-Feb       Impact factor: 2.467

9.  Multiple airborne allergen-induced eosinophilic chronic rhinosinusitis murine model.

Authors:  Sang Chul Park; Soo In Kim; Chi Sang Hwang; Hyung-Ju Cho; Joo-Heon Yoon; Chang-Hoon Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-16       Impact factor: 2.503

10.  Risk of obstructive sleep apnea in African American patients with chronic rhinosinusitis.

Authors:  Jessica W Hui; Jason Ong; James J Herdegen; Hajwa Kim; Christopher D Codispoti; Vahid Kalantari; Mary C Tobin; Robert P Schleimer; Pete S Batra; Phillip S LoSavio; Mahboobeh Mahdavinia
Journal:  Ann Allergy Asthma Immunol       Date:  2017-04-27       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.